[{"address1": "7800 Susquehanna St.", "address2": "Suite 505", "city": "Pittsburgh", "state": "PA", "zip": "15208", "country": "United States", "phone": "412-901-0315", "website": "https://www.lipella.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan  Kaufman M.B.A., Ph.D.", "age": 58, "title": "Co-Founder, Chairman, CEO, President, Secretary & Treasurer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 204133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael B. Chancellor M.D.", "age": 66, "title": "Co-Founder, Chief Medical Officer & Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 195833, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas  Johnston CPA", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 185000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele  Gruber", "title": "Director of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katie  Johnston", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.42, "open": 3.3, "dayLow": 3.12, "dayHigh": 3.3347, "regularMarketPreviousClose": 3.42, "regularMarketOpen": 3.3, "regularMarketDayLow": 3.12, "regularMarketDayHigh": 3.3347, "payoutRatio": 0.0, "beta": 0.297, "forwardPE": -0.97812504, "volume": 210663, "regularMarketVolume": 210663, "averageVolume": 2329654, "averageVolume10days": 13213640, "averageDailyVolume10Day": 13213640, "bid": 3.07, "ask": 3.19, "bidSize": 1, "askSize": 1, "marketCap": 3783919, "fiftyTwoWeekLow": 2.21, "fiftyTwoWeekHigh": 12.0, "priceToSalesTrailing12Months": 7.8255653, "fiftyDayAverage": 3.07816, "twoHundredDayAverage": 3.754155, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2851599, "profitMargins": 0.0, "floatShares": 853799, "sharesOutstanding": 1208920, "sharesShort": 30821, "sharesShortPriorMonth": 72442, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0255, "heldPercentInsiders": 0.24348, "heldPercentInstitutions": 0.06102, "shortRatio": 0.54, "shortPercentOfFloat": 0.0312, "impliedSharesOutstanding": 1208920, "bookValue": 1.337, "priceToBook": 2.341062, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -4263476, "trailingEps": -4.29, "forwardEps": -3.2, "lastSplitFactor": "1:8", "lastSplitDate": 1731024000, "enterpriseToRevenue": 5.897, "enterpriseToEbitda": -0.655, "52WeekChange": -0.57673264, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 3.13, "targetHighPrice": 10.0, "targetLowPrice": 10.0, "targetMeanPrice": 10.0, "targetMedianPrice": 10.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 1353734, "totalCashPerShare": 1.12, "ebitda": -4355956, "totalDebt": 70830, "quickRatio": 1.975, "currentRatio": 2.966, "totalRevenue": 483533, "debtToEquity": 4.855, "revenuePerShare": 0.505, "returnOnAssets": -1.0894799, "returnOnEquity": -2.3167, "grossProfits": -2521518, "freeCashflow": -2148772, "operatingCashflow": -3688044, "revenueGrowth": -0.228, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -18.15644, "financialCurrency": "USD", "symbol": "LIPO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1740168689, "regularMarketChangePercent": -8.479531, "regularMarketPrice": 3.13, "exchange": "NCM", "messageBoardId": "finmb_35907207", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "REGULAR", "longName": "Lipella Pharmaceuticals Inc.", "shortName": "Lipella Pharmaceuticals Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1671460200000, "regularMarketChange": -0.28999996, "regularMarketDayRange": "3.12 - 3.3347", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2329654, "fiftyTwoWeekLowChange": 0.9200001, "fiftyTwoWeekLowChangePercent": 0.41628963, "fiftyTwoWeekRange": "2.21 - 12.0", "fiftyTwoWeekHighChange": -8.87, "fiftyTwoWeekHighChangePercent": -0.7391667, "fiftyTwoWeekChangePercent": -57.673264, "epsTrailingTwelveMonths": -4.29, "epsForward": -3.2, "fiftyDayAverageChange": 0.051840067, "fiftyDayAverageChangePercent": 0.016841251, "twoHundredDayAverageChange": -0.6241548, "twoHundredDayAverageChangePercent": -0.16625707, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-12-20", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "displayName": "Lipella Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]